MedPath

BILASTINA TEVA 20 MG COMPRIMIDOS BUCODISPERSABLES EFG

BILASTINA TEVA 20 MG COMPRIMIDOS BUCODISPERSABLES EFG

Commercialized
Register Number

88343

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Nov 30, 2022

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number88343
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BILASTINAActive
Quantity: 20 mg
Name: BILASTINA

ATC CLASSIFICATION (3)

R06A
R06AX
R06AX29

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.